GlassScriptPhysician profile
Nancy L Panter
NPI 1104933712
$590.82
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $157.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.92 | 2019-2020 | |
| Amgen INC. | $69.91 | 2019 | |
| Astellas Pharma US INC | $54.18 | 2020 | |
| Abbvie INC. | $39.92 | 2019 | |
| Amarin Pharma, INC. | $39.22 | 2019 | |
| Coopersurgical, INC. | $33.17 | 2019-2020 | |
| Therapeuticsmd, INC. | $28.72 | 2019-2020 | |
| Allergan, INC. | $27.09 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $24.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.19 | 2019 | |
| Circassia INC. | $22.92 | 2019 | |
| Inogen, INC. | $18.87 | 2020 | |
| Sanofi-Aventis U.S. LLC | $18.54 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.93 | 2019 | |
| Novo Nordisk INC | $16.32 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $15.19 | 2019 | |
| Neos Therapeutics, LP | $13.28 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.15 | 2019 | |
| Phadia US INC. | $11.67 | 2019 | |
| Merck Sharp & Dohme LLC | $11.46 | 2019 | |
| Vanda Pharmaceuticals INC. | $11.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Panter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.